Raynaud's phenomenon

FM Wigley, NA Flavahan - New England Journal of Medicine, 2016 - Mass Medical Soc
Raynaud’s Phenomenon | New England Journal of Medicine Skip to main content The New
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …

Clinical treatment options in scleroderma: recommendations and comprehensive review

M Zhao, J Wu, H Wu, AH Sawalha, Q Lu - Clinical Reviews in Allergy & …, 2022 - Springer
There are two major clinical subsets of scleroderma:(i) systemic sclerosis (SSc) is a complex
systemic autoimmune disorder characterized by inflammation, vasculopathy, and excessive …

Raynaud's phenomenon: pathogenesis and management

R Bakst, JF Merola, AG Franks Jr, M Sanchez - Journal of the American …, 2008 - Elsevier
Raynaud's phenomenon is a common clinical disorder for which patients frequently seek the
expertise and care of dermatologists. It is manifested by recurrent vasospasm of the fingers …

'Reversible chemical sphincterotomy'by local application of glyceryl trinitrate

PB Loder, MA Kamm, RJ Nicholls… - British journal of …, 1994 - Wiley Online Library
Nitric oxide has emerged as one of the most important neurotransmitters mediating internal
anal sphincter relaxation. The effect of glyceryl trinitrate, a nitric oxide donor, on anal tone …

Systemic sclerosis: hypothesis-driven treatment strategies

C Charles, P Clements, DE Furst - The Lancet, 2006 - thelancet.com
We review data from controlled trials and randomised controlled trials to examine the
hypothesis for the pathogenesis of systemic sclerosis. Strategies used to treat the vascular …

Vascular involvement in systemic sclerosis (scleroderma)

D Pattanaik, M Brown… - Journal of inflammation …, 2011 - Taylor & Francis
Systemic sclerosis (SSc) is an acquired multiorgan connective tissue disease with variable
mortality and morbidity dictated by clinical subset type. The etiology of the basic disease and …

Local nitroglycerin for treatment of anal fissures: an alternative to lateral sphincterotomy?

H Bacher, HJ Mischinger, G Werkgartner… - Diseases of the colon & …, 1997 - Springer
PURPOSE: Nitric oxide is an important neurotransmitter mediating internal anal sphincter
relaxation. Patients suffering from fissure-in-ano were treated with topical nitroglycerine. The …

MQX‐503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial

L Chung, L Shapiro, D Fiorentino… - … : Official Journal of …, 2009 - Wiley Online Library
Objective Raynaud's phenomenon (RP) affects 3–9% of the general population and> 90% of
patients with systemic sclerosis. Nitrates are often prescribed for the treatment of RP, but …

Sustained-release transdermal glyceryl trinitrate patches as a treatment for primary and secondary Raynaud's phenomenon

LS Teh, J Manning, T Moore, MP Tully… - …, 1995 - academic.oup.com
A randomized, double-blind, placebo controlled, cross-over study was conducted to
determine the clinical efficacy of and patient tolerance to sustained-release glyceryl trinitrate …

Advances in the treatment of Raynaud's phenomenon

TL Levien - Vascular health and risk management, 2010 - Taylor & Francis
Raynaud's phenomenon is a common condition characterized by vasospasm of the digital
arteries and resulting cyanosis and redness. It often does not require pharmacologic …